[Federal Register Volume 84, Number 246 (Monday, December 23, 2019)]
[Notices]
[Pages 70552-70553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27554]



[[Page 70552]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-20-20DV; Docket No. CDC-2019-0114]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled ``Chronic Q Fever in the United 
States: Enhanced Clinical Surveillance.'' This enhanced medical 
surveillance for chronic Q fever will collect specific clinical data 
not otherwise collected during routine public health surveillance to 
allow for better characterization of the clinical presentation and risk 
factors of chronic Q fever in the United States.

DATES: CDC must receive written comments on or before February 21, 
2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0114 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, of the Information 
Collection Review Office, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Chronic Q Fever in the United States: Enhanced Clinical 
Surveillance--New--National Center for Emerging Zoonotic and Infectious 
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Q fever is a worldwide zoonosis caused by Coxiella burnetii with 
acute and chronic disease presentations. Chronic Q fever can manifest 
months to years after the primary infection and is rare, occurring in 
<5% of persons with an acute infection. Chronic Q fever can take on 
several clinical forms, including endocarditis, chronic hepatitis, 
chronic vascular infections, osteomyelitis, and osteoarthritis. In the 
United States, Q fever cases are reported via the National Notifiable 
Disease Surveillance System; however, limited information is collected 
on the various clinical manifestation of chronic Q fever or patients 
pre-existing risk factors. Data on outcomes other than death or 
hospitalizations are not collected by the current surveillance.
    Because of this lack of data, the true burden and proportion of 
cases exhibiting endocarditis and other forms of chronic Q fever in the 
United States is unknown. We plan to establish an enhanced medical 
surveillance for chronic Q fever by working with consulting clinicians 
to gather additional and more specific clinical data not otherwise 
collected during routine public health surveillance for chronic Q 
fever. This information will allow for better characterization of the 
clinical presentation and risk factors of chronic Q fever in the United 
States. The results will help characterize an under-recognized disease 
and provide valuable data to educate physicians on identifying and 
diagnosing these cases. CDC is requesting approval for five burden 
hours annually. There is no cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Physician.....................  Chronic Q fever               15               1           20/60               5
                                 enhanced
                                 surveillance
                                 report form.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............               5
----------------------------------------------------------------------------------------------------------------



[[Page 70553]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-27554 Filed 12-20-19; 8:45 am]
 BILLING CODE 4163-18-P